Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Neuropsychiatric Disease and Treatment|April 23, 2021
Early Improvement of Psychiatric Symptoms with Long-Acting Injectable Antipsychotic Predicts Subsequent Social Functional Remission in Patients with SchizophreniaTakashi Ohnishi, Akihide Wakamatsu, Hisanori KobayashiPsychiatry and Clinical Neurosciences|May 21, 2022
Different symptomatic improvement pattern revealed by factor analysis between placebo response and response to Esketamine in treatment resistant depressionTakashi Ohnishi, Akihide Wakamatsu, Hisanori KobayashiPharmacoeconomics - Open|November 1, 2018
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in JapanTimothy Bolt, Hisanori Kobayashi, Jörg MahlichRheumatology and Therapy|October 8, 2020
Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance DataHirohito Shimizu, Hisanori Kobayashi, Masayoshi Kanbori, et al.Rheumatology and Therapy|March 2, 2020
Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance DataHirohito Shimizu, Hisanori Kobayashi, Masayoshi Kanbori, et al.International Journal of Geriatric Psychiatry|December 19, 2015
The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysisHisanori Kobayashi, Takashi Ohnishi, Ryoko Nakagawa, et al.Modern Rheumatology|July 18, 2020
Clinical response among golimumab-treated Japanese patients with rheumatoid arthritis by number of previous biologic therapies: Real-world evidence from post-hoc analysis of post-marketing surveillance dataHirohito Shimizu, Hisanori Kobayashi, Masayoshi Kanbori, et al.Modern Rheumatology|July 18, 2020
Effectiveness of golimumab in rheumatoid arthritis patients with inadequate response to first-line biologic therapy: Results from a Japanese post-marketing surveillance studyHirohito Shimizu, Hisanori Kobayashi, Masayoshi Kanbori, et al.Innovations in Clinical Neuroscience|February 22, 2020
Psychiatric Comorbidities in Adult Attention-deficit/Hyperactivity Disorder: Prevalence and Patterns in the Routine Clinical SettingTakashi Ohnishi, Hisanori Kobayashi, Tsutomu Yajima, et al.Rheumatology and Therapy|February 23, 2018
Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis PatientsMasateru Okazaki, Hisanori Kobayashi, Yutaka Ishii, et al.Pageof 4